Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Mission Bio logo — The Tapestri® Platform; the only technology that provides si...

Mission Bio

The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution.

Founded 2014 United States South San Francisco, United States 90 employees Growth Total: $186.50M Biotechnology, Health Care +1

General Information

Company Name Mission Bio
Founded Year 2014
Location United States South San Francisco, United States
Employees 90
Industries Biotechnology, Health Care, Clean Energy
Funding Stage Growth
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Mission Bio. To contact Mission Bio, visit missionbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mission Bio compare?

A PDF of Mission Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mission Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 03, 2026

Mission Bio is attending the IJC Symposium in Barcelona featuring a talk by Dr. Enise Ceran.

Promotion Launched Oct 23, 2026

Mission Bio launched a promotion offering 33% off the Tapestri Instrument and expansion kits for labs adding single-cell multiomics.

Mission Bio a competitor of yours? Have our desk watch it

About Mission Bio

Mission Bio, founded in 2014, is a key player in the Biotechnology and Health Care industries, with a focus also on Clean Energy. Headquartered in the United States, the company has carved a niche with its Tapestri® Platform, the only technology that delivers single-cell targeted DNA sequencing at single-base resolution.

The firm originated from Adam Abate's lab at the University of California, San Francisco (UCSF), underscoring its foundation in cutting-edge research and innovation in droplet microfluidics. Mission Bio stands out for its commitment to aiding researchers and clinicians in the advancement of precision medicine through unparalleled precision engineering and bioinformatics.

In its latest funding round, Mission Bio attracted a Growth Equity VC investment on 01 August 2025, with backing from Ally Bridge Group. This investment underscores investor confidence in their innovative technology and future growth potential.

Business keywords: Single-cell Targeted DNA Sequencing, Precision Genomics, Droplet Microfluidics, Single-cell Multi-omics Platform, Bioinformatics Support, Oncology Blood Cancers, Solid Tumors, Genome Editing Validation, Precision Medicine, Disease Progression Detection, Treatment Response Analysis, Single-cell Biology, High-throughput Biology, Innovative Biochemistry, Genotype and Phenotype Analysis

Services & Products

Tapestri Platform
Single-cell Genomic Analysis
Precision Medicine Solutions
CRISPR Genotoxicity Mapping
Multi-omic Data Integration

Target Customers

Cancer Researchers Biotechnology Companies Pharmaceutical Companies Clinical Researchers Genomic Scientists

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Growth Equity VC Undisclosed 1
Ally Bridge Group
Ally Bridge Group
01 Aug 2025
Debt Financing $40.00M -
01 Jan 2022
Series C $70.00M 6
Novo Holdings Mayfield Cota Capital
Novo Holdings, Mayfield +4
01 Aug 2020
Early VC $100.00K -
01 Mar 2020
Series B $30.00M 3
Mayfield Cota Capital
Mayfield, Cota Capital +1
01 Dec 2018
Series A $28.40M 4
Foothill Ventures Mayfield Mighty Capital
Foothill Ventures, Mayfield +2
01 Jul 2018
Grant $1.00M 1
National Human Genome Research Institute
National Human Genome Research Institute
01 Dec 2017
Debt Financing $10.00M 2
Mayfield Seabed VC
Mayfield, Seabed VC
01 Jun 2017
Debt Financing $6.00M 1
Life Science Angels
Life Science Angels
01 Feb 2017
Seed Undisclosed 3
Fusion Fund The Angels' Forum
Fusion Fund, The Angels' Forum +1
01 Jul 2016

View All 14 Funding Rounds

Mission Bio Alternatives & Competitors

View All Alternatives
Mission Bio vs
CARTANA
CARTANA United States

Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬

IPO
2093 employees
Biotechnology, Health Care
Compare Mission Bio vs CARTANA
Mission Bio vs
Bruker Cellular Analysis
Bruker Cellular Analysis United States

Understand The Life of Single Cells

Series D
106 employees
Biotechnology, Health Care
Compare Mission Bio vs Bruker Cellular Analysis
Mission Bio vs
Celsius Therapeutics
Celsius Therapeutics United States

On a quest to leverage the power of single cell genomics to discover novel drug targets and precisio...

Acquired
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Mission Bio

The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution.
Mission Bio was founded in 2014.
Mission Bio is headquartered in South San Francisco, United States.
Mission Bio operates in Biotechnology, Health Care and Clean Energy. Its work centres on Single-cell Targeted DNA Sequencing, Precision Genomics, Droplet Microfluidics and Single-cell Multi-omics Platform. Its customers include Cancer Researchers, Biotechnology Companies and Pharmaceutical Companies.
Mission Bio has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Mission Bio has approximately 90 employees.
Mission Bio has completed 14 funding rounds, raising a total of $186.50M. The latest funding stage is Growth.
Mission Bio offers: Tapestri Platform, Single-cell Genomic Analysis, Precision Medicine Solutions, CRISPR Genotoxicity Mapping, Multi-omic Data Integration.
Top alternatives and competitors to Mission Bio include CARTANA, Bruker Cellular Analysis, Celsius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mission Bio and CARTANA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mission Bio, https://bouncewatch.com/company/mission-bio, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout